Search Results - "Moon, Ki H"

Low Temperature Fracture Properties of Polyphosphoric Acid Modified Asphalt Mixtures by Zegeye, Eyoab T, Moon, Ki H, Turos, Mugur, Clyne, Timothy R, Marasteanu, Mihai O

“…AbstractThe low temperature fracture properties of polyphosphoric acid (PPA) modified mixtures are evaluated and compared with those of polymer modified…”
Get full text

Asia and the OSCE by Ban Ki-moon, H. E.

Get full text

Efficacy and safety of mirodenafil, a new oral phosphodiesterase type 5 inhibitor, for treatment of erectile dysfunction by Paick, Jae-Seung, Ahn, Tai Y, Choi, Hyung K, Chung, Woo-Sik, Kim, Je J, Kim, Sae C, Kim, Sae W, Lee, Sung W, Min, Kweon S, Moon, Ki H, Park, Jong K, Park, Kwangsung, Park, Nam C, Suh, Jun-Kyu, Yang, Dae Y, Jung, Hyung-Gi

“…Mirodenafil is a newly developed oral phosphodiesterase type 5 inhibitor, currently under investigation as a treatment for erectile dysfunction (ED). We…”
Get full text

DIALYSIS CARDIOVASCULAR COMPLICATIONS 2 by Rothuizen, T. C., Ocak, G., Verschuren, J. J., Dekker, F. W., Rabelink, T. J., Jukema, J. W., Rotmans, J. I., Silva, V., Raimann, J. G., Grassmann, A., Marcelli, D., Usvyat, L., Canaud, B., Kotanko, P., Pecoits-Filho, R., Consortium, M., Strippoli, G. F., Sue, Y.-M., Tang, C.-H., Chen, T.-H., Hong, C.-Y., Ochi, A., Ishimura, E., Masuda, M., Tsujimoto, Y., Okuno, S., Tabata, T., Nishizawa, Y., Inaba, M., Moon Ki, H., Do Hyoung, K., Min Jee, H., Hyun, K., Wang Soo, L., Su-Hyun, K., Selim, G., Stojceva-Taneva, O., Tozija, L., Dzekova-Vidimliski, P., Trajceska, L., Gelev, S., Amitov, V., Petronievic, Z., Sikole, A., Kee, Y. K., Kim, Y. L., Han, J. H., Oh, H. J., Park, J. T., Han, S. H., Yoo, T.-H., Kang, S.-W., Okute, Y., Shoji, T., Sonoda, M., Kuwamura, Y., Shioi, A., Tahara, H., Emoto, M., El Amrani, M., Asserraji, M., Benyahia, M., Galloway, P. A., Yiu, V., Hiemstra, T. F., Nilssen, C., Zannad, F., Jardine, A., Schmieder, R., Fellstrom, B., Holdaas, H., Mjoen, G., Eftimovska - Otovic, N., Babalj - Banskolieva, E., Bogdanoska - Kostadinoska, S., Grozdanovski, R., Silva, B. C., Freitas, G. R., Silva, V. B., Abensur, H., Luders, C., Pereira, B. J., Castro, M. C., Oliveira, R. B., Moyses, R. M., Elias, R. M., Perez De Jose, A., Abad, S., Vega, A., Reque, J., Quiroga, B., Lopez-Gomez, J. M., Sasaki, K., Yamguchi, K., Hesaka, A., Iwahashi, E., Sakai, S., Fujimoto, T., Minami, S., Fujita, Y.

Get full text

ORIGINAL RESEARCH—ED PHARMACOTHERAPY: Efficacy and Safety of Mirodenafil, A New Oral Phosphodiesterase Type 5 Inhibitor, for Treatment of Erectile Dysfunction by Paick, Jae‐Seung, Ahn, Tai Y., Choi, Hyung K., Chung, Woo‐Sik, Kim, Je J., Kim, Sae C., Kim, Sae W., Lee, Sung W., Min, Kweon S., Moon, Ki H., Park, Jong K., Park, Kwangsung, Park, Nam C., Suh, Jun‐Kyu, Yang, Dae Y., Jung, Hyung‐Gi

“…Mirodenafil is a newly developed oral phosphodiesterase type 5 inhibitor, currently under investigation as a treatment for erectile dysfunction (ED). We…”
Get full text